Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06512168 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Measuring Aided Language Development

Study acronym: MALD
StatusRecruiting
PhaseNot applicable
Started2025-04-01
View on ClinicalTrials.gov ↗

Amendment history

2025-05-13
minor
Study Identification, Study Status v3
Re-verified, no change to tracked fields
2025-04-28
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2025-02-19
minor
Study Status, Oversight v1
Start date2024-11-01→2025-04-01
2024-07-16
minor
Original filing
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Trial Details
NCT Number NCT06512168
Lead Sponsor University of Central Florida
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD), University of New Mexico, University of Wisconsin, Milwaukee
Conditions Down Syndrome, Cerebral Palsy, Apraxia of Speech, Speech Sound Disorder, Speech Disorders in Children, Speech and Language Disorder
Enrollment 60 participants
Start Date 2025-04-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-16